Published in J Am Coll Cardiol on May 17, 2007
Validation Of Quantitative Flow Ratio (QFR) - Derived Virtual Angioplasty (QIMERA-I) | NCT04200469
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J (2013) 1.76
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J (2014) 1.74
Computed fractional flow reserve (FFTCT) derived from coronary CT angiography. J Cardiovasc Transl Res (2013) 1.49
CT angiography for evaluation of coronary artery disease in inner-city outpatients: an initial prospective comparison with stress myocardial perfusion imaging. Int J Cardiovasc Imaging (2008) 1.42
Tc-99m sestamibi single photon emission computed tomography for guiding percutaneous coronary intervention in patients with multivessel disease: a comparison with quantitative coronary angiography and fractional flow reserve. Int J Cardiovasc Imaging (2009) 1.41
Does grafting coronary arteries with only moderate stenosis affect long-term mortality? J Thorac Cardiovasc Surg (2015) 1.38
Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson (2012) 1.05
The role of multi-slice computed tomography in stable angina management: a current perspective. Neth Heart J (2011) 1.04
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2012) 1.04
Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiography. Int J Cardiovasc Imaging (2009) 1.02
Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc (2009) 1.00
Catheter-based functional metrics of the coronary circulation. J Nucl Cardiol (2016) 0.96
CT fractional flow reserve: the next level in non-invasive cardiac imaging. Neth Heart J (2012) 0.96
Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int J Cardiovasc Imaging (2011) 0.94
Perfusion cardiovascular magnetic resonance: Comparison of an advanced, high-resolution and a standard sequence. J Cardiovasc Magn Reson (2012) 0.92
Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessels (2014) 0.91
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention: a meta-analysis. Heart (2015) 0.90
Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment. Br J Radiol (2011) 0.88
Epicardial adipose tissue reflects the presence of coronary artery disease: comparison with abdominal visceral adipose tissue. Biomed Res Int (2015) 0.87
Coronary pressure-derived fractional flow reserve in the assessment of coronary artery stenoses. Eur Radiol (2012) 0.87
Diagnostic performance of transluminal attenuation gradient and fractional flow reserve by coronary computed tomographic angiography (FFR(CT)) compared to invasive FFR: a sub-group analysis from the DISCOVER-FLOW and DeFACTO studies. Int J Cardiovasc Imaging (2015) 0.87
Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access. Clin Res Cardiol (2009) 0.86
Fractional flow reserve application in everyday practice: adherence to clinical recommendations. Cardiovasc Diagn Ther (2013) 0.86
Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept. Circulation (2014) 0.86
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol (2012) 0.85
Fractional Flow Reserve Guided Percutaneous Coronary Intervention Improves Clinical Outcome with Reduced Cost in Contemporary Clinical Practice. Chin Med J (Engl) (2015) 0.85
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson (2016) 0.84
Fractional flow reserve: the past, present and future. Korean Circ J (2012) 0.83
Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan. Cardiovasc Interv Ther (2014) 0.82
Shedding light on the gray zone. J Thorac Dis (2016) 0.81
Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease. Eur Heart J (2011) 0.81
Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J (2014) 0.80
Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular ultrasound analysis. Int J Cardiovasc Imaging (2015) 0.80
Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center. Neth Heart J (2010) 0.80
Treating stable ischemic heart disease with percutaneous coronary intervention - The debate continues. Cardiovasc Diagn Ther (2012) 0.80
Functional relevance of coronary artery disease by cardiac magnetic resonance and cardiac computed tomography: myocardial perfusion and fractional flow reserve. Biomed Res Int (2015) 0.80
Cardiac MRI for myocardial ischemia. Methodist Debakey Cardiovasc J (2013) 0.80
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus. Cardiovasc Diabetol (2016) 0.80
Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. Int J Cardiol (2015) 0.79
Fractional flow reserve: Current applications and overview of the available data. World J Clin Cases (2015) 0.79
Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Eur Heart J Acute Cardiovasc Care (2012) 0.79
Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve. Int J Cardiovasc Imaging (2011) 0.79
Three dimensional quantitative coronary angiography can detect reliably ischemic coronary lesions based on fractional flow reserve. J Korean Med Sci (2015) 0.79
Evaluating the impact of fractional flow reserve-guided percutaneous coronary intervention in intermediate coronary artery lesions on the mode of treatment and their outcomes: An Iranian experience. ARYA Atheroscler (2015) 0.79
Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease. J Cardiovasc Magn Reson (2014) 0.79
The Impact of Fractional Flow Reserve on Revascularization. Cardiol Ther (2015) 0.79
Real-world use of fractional flow reserve in Germany: results of the prospective ALKK coronary angiography and PCI registry. Clin Res Cardiol (2016) 0.79
Validation of the "smart" minimum FFR Algorithm in an unselected all comer population of patients with intermediate coronary stenoses. Int J Cardiovasc Imaging (2017) 0.78
A systematic review of imaging anatomy in predicting functional significance of coronary stenoses determined by fractional flow reserve. Int J Cardiovasc Imaging (2017) 0.78
Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates. Circ Cardiovasc Imaging (2015) 0.78
Left ventricular end-diastolic pressure affects measurement of fractional flow reserve. Cardiovasc Revasc Med (2013) 0.78
Myocardial perfusion imaging and infarct characterization using multidetector cardiac computed tomography. World J Cardiol (2010) 0.78
Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery disease. PLoS One (2012) 0.78
Comprehensive assessment of coronary fractional flow reserve. Arch Med Sci (2015) 0.78
Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging (2017) 0.78
The value of noninvasive computed tomography derived fractional flow reserve in our current approach to the evaluation of coronary artery stenosis. Curr Opin Cardiol (2016) 0.78
Percutaneous coronary intervention in the UK: recommendations for good practice 2015. Heart (2015) 0.78
Diagnostic performance of instantaneous wave-free ratio for the evaluation of coronary stenosis severity confirmed by fractional flow reserve: A PRISMA-compliant meta-analysis of randomized studies. Medicine (Baltimore) (2016) 0.78
Physiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow Reserve. Korean J Radiol (2016) 0.77
Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design. Cardiovasc Diabetol (2016) 0.77
Fractional flow reserve guided revascularization in daily practice: clinical judgment does not always meet science. Cardiovasc Diagn Ther (2013) 0.77
Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome. J Am Heart Assoc (2015) 0.77
Coronary pressure measurement based decision making for percutaneous coronary intervention. Curr Cardiol Rev (2009) 0.77
320-row CT coronary angiography predicts freedom from revascularisation and acts as a gatekeeper to defer invasive angiography in stable coronary artery disease: a fractional flow reserve-correlated study. Eur Radiol (2013) 0.77
Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study. Heart Vessels (2016) 0.77
Efficiencies of intracoronary sodium nitroprusside on fractional flow reserve measurement. Int J Clin Exp Med (2015) 0.76
The vulnerable plaque: the real villain in acute coronary syndromes. Open Cardiovasc Med J (2011) 0.76
The relationship between fractional flow reserve, platelet reactivity and platelet leukocyte complexes in stable coronary artery disease. PLoS One (2013) 0.76
From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? Clujul Med (2014) 0.76
Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals. Int J Cardiovasc Imaging (2009) 0.76
Clinical applications of fractional flow reserve in bifurcation lesions. J Geriatr Cardiol (2012) 0.76
The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review. Tex Heart Inst J (2009) 0.76
Anatomical versus functional assessment of coronary artery disease: direct comparison of computed tomography coronary angiography and magnetic resonance myocardial perfusion imaging in patients with intermediate pre-test probability. Int J Cardiovasc Imaging (2014) 0.76
The impact of image resolution on computation of fractional flow reserve: coronary computed tomography angiography versus 3-dimensional quantitative coronary angiography. Int J Cardiovasc Imaging (2015) 0.76
Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. JACC Cardiovasc Imaging (2017) 0.76
CT-based myocardial ischemia evaluation: quantitative angiography, transluminal attenuation gradient, myocardial perfusion, and CT-derived fractional flow reserve. Int J Cardiovasc Imaging (2015) 0.76
Revascularization in multivessel CAD: a functional approach. Nat Rev Cardiol (2012) 0.75
Value of FFR in clinical practice. Indian Heart J (2015) 0.75
Safety and efficacy of a novel technique in the use of fractional flow reserve in complex coronary artery lesions. Chin Med J (Engl) (2015) 0.75
Physiologic approach for coronary intervention. Korean J Intern Med (2012) 0.75
Funtional significance of the intermediate lesion in a single coronary artery assessed by fractional flow reserve. Korean J Intern Med (2014) 0.75
Progress and Current State of Coronary CT. Ann Vasc Dis (2011) 0.75
Fractional Flow Reserve in Acute Myocardial Infarction: A Guide for Non-Culprit Lesions? Cardiol Ther (2015) 0.75
Percutaneous Coronary Intervention Enhances Accelerative Wave Intensity in Coronary Arteries. PLoS One (2015) 0.75
Non-invasive detection of vulnerable coronary plaque. World J Cardiol (2011) 0.75
Coronary CT angiography: Beyond morphological stenosis analysis. World J Cardiol (2013) 0.75
Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond. Cardiovasc Diagn Ther (2012) 0.75
Intermittent spastic coronary occlusion at site of non-significant atherosclerotic lesion requiring stent implantation. Neth Heart J (2008) 0.75
Adult post-mortem imaging in traumatic and cardiorespiratory death and its relation to clinical radiological imaging. Br J Radiol (2014) 0.75
Non-invasive assessment of functionally significant coronary stenoses through mathematical analysis of spectral ECG components. Open Heart (2014) 0.75
Current use of fractional flow reserve: a nationwide survey. Tex Heart Inst J (2014) 0.75
ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation. Indian Heart J (2014) 0.75
Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions. Am J Cardiovasc Dis (2013) 0.75
Role of coronary physiology in the contemporary management of coronary artery disease. World J Clin Cases (2015) 0.75
The physiologic evaluation of stenosis by transthoracic Doppler: a bit of theory, a lot of practice. J Am Soc Echocardiogr (2011) 0.75
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med (2009) 13.42
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Universal definition of myocardial infarction. Circulation (2007) 11.69
A prospective natural-history study of coronary atherosclerosis. N Engl J Med (2011) 10.66
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J (2005) 6.86
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med (2009) 5.26
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol (2013) 5.11
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2003) 4.70
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet (2003) 4.68
Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol (2006) 4.37
Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med (2014) 4.37
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation (2007) 4.24
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 3.87
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation (2006) 3.50
Guidelines on myocardial revascularization. Eur J Cardiothorac Surg (2010) 3.47
Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med (2013) 3.46
A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol (2007) 3.28
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet (2007) 3.20
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J (2012) 3.19
Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol (2006) 3.16
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol (2010) 2.89
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation (2007) 2.85
DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J (2004) 2.85
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol (2011) 2.85
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83
Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol (2008) 2.81
Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med (2010) 2.80
Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol (2008) 2.75
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA (2005) 2.74
Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J (2006) 2.74
Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol (2008) 2.68
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol (2006) 2.61
Gender differences in the management and clinical outcome of stable angina. Circulation (2006) 2.59
Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation (2010) 2.56
Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol (2006) 2.54
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation (2010) 2.54
Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol (2010) 2.51
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J (2006) 2.48
Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation (2005) 2.35
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation (2010) 2.30
The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol (2012) 2.27
2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management. Heart (2013) 2.18
Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. JACC Cardiovasc Imaging (2011) 2.18
N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol (2013) 2.15
Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J (2008) 2.13
Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol (2003) 2.08
Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv (2010) 2.08
A comparison of the lateral and posterior approach for brachial plexus block. Reg Anesth Pain Med (2006) 2.07
Characterizing vulnerable plaque features with intravascular elastography. Circulation (2003) 2.07
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv (2010) 2.06
Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology (2010) 2.04
64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol (2007) 2.04
Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Int J Cardiol (2012) 2.04
Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J (2006) 2.02
Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation (2004) 2.02
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA (2009) 1.99
Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol (2004) 1.99
Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis. Radiology (2007) 1.97
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention (2009) 1.94
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90
Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation (2003) 1.90
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90